Evidence map›Paper›PMID 25269700›Full record

ArticleJournal of the National Cancer Institute2014

Applying big GWAS data to clarify the role of obesity in Barrett's esophagus and esophageal adenocarcinoma.

Julian A Abrams, Amitabh Chak

Abstract readEditorialComment
PubMed Publisher
In one paragraph

Article in Journal of the National Cancer Institute, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Julian A AbramsDivision of Digestive and Liver Disease, Columbia University Medical Center, New York, NY (JAA); Division of Gastroenterology and Liver Disease, Case Western Reserve University, Cleveland, OH (AC). ja660@columbia.edu.
Amitabh ChakDivision of Digestive and Liver Disease, Columbia University Medical Center, New York, NY (JAA); Division of Gastroenterology and Liver Disease, Case Western Reserve University, Cleveland, OH (AC).

Funding

Targeting 15-PGDH in Colon Cancer Prognosis, Prediction, Treatment and PreventionP50CA150964 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI MARKOWITZ, SANFORD D. · 2011 to 2022
$24.6M
Whole Exome Approaches for Esophageal Adenocarcinoma Susceptibility GenesU54CA163060 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI CHAK, AMITABH, GUDA, KISHORE · 2011 to 2022
$14.0M
NCI NIH HHS U54 CA163060
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Body Mass IndexMendelian Randomization AnalysisPolymorphism, Single NucleotideAdenocarcinomaBarrett EsophagusEsophageal NeoplasmsFemaleHumansMaleObesityPrecancerous Conditions

Identifiers

PMID25269700

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.